Related Experiment Videos
[Hypertensive cardiopathy--an adaptive or a pathologic phenomenon?]
Insights
Hypertensive cardiopathy, characterized by left ventricular hypertrophy due to increased blood pressure, progresses from adaptive to pathological stages. Echocardiography is key for assessing this cardiovascular risk factor.
Area of Science:
- Cardiology
- Pathophysiology
- Hypertension Research
Context:
- Hypertensive cardiopathy, defined as left ventricular hypertrophy secondary to sustained hypertension, presents complex physiopathological mechanisms and clinical manifestations.
- It is associated with all severities of arterial hypertension, not just severe forms.
- Understanding its progression is crucial for managing cardiovascular health.
Purpose:
- To elucidate the physiopathological mechanisms and clinical aspects of hypertensive cardiopathy.
- To highlight the role of increased parietal tension as the primary initiator of myocardial hypertrophy.
- To detail the progressive nature of hypertensive cardiopathy, from adaptive to pathological hypertrophy, affecting cardiac function.
Summary:
- Increased parietal tension (hemodynamic hypertrophy) is identified as the main factor initiating myocardial hypertrophy in hypertensive cardiopathy.
- The condition evolves progressively, with initially adaptive hypertrophy becoming pathological, impairing diastolic and then systolic cardiac function, potentially leading to congestive cardiac insufficiency.
- Echocardiography is presented as the most accurate method for quantifying hypertrophy, assessing cardiac performance, and identifying characteristic features of hypertensive cardiopathy.
Impact:
- Provides a clearer understanding of hypertensive cardiopathy's progression and underlying mechanisms.
- Emphasizes echocardiography's critical role in diagnosis and management.
- Establishes hypertensive hypertrophy as a significant supplementary cardiovascular risk factor, underscoring the need for early detection and intervention.
Abstract:
The hypertensive cardiopathy is a controversial entity as regards the physiopathological mechanisms and clinical aspects. Defined as the hypertrophy of the left ventricle, secondary to the permanent tension increases, it accompanies not only the severe forms of arterial hypertension but also the medium and mild ones. In the authors' opinion, based on numerous experimental and clinical studies, the main factor that initiates the myocardial hypertrophy is the increased parietal tension (hemodynamic hypertrophy). The natural evolution is progressive, the myocardial hypertrophy initially adaptive becomes pathological and the cardiac performance is affected gradually, first in its diastolic and then in its systolic component, up to the final stage of congestive cardiac insufficiency. The structural changes of the myocardial fibre also document the adaptive and pathological hypertrophy, the alteration of the myocardial contractility consisting in the difficulty of transforming the chemical energy into mechanical work. The clinical aspects show an incipient myocardial hypertrophy, considered adaptive, since the cardiac performance is normal; an important hypertrophy affecting the diastolic component and the hypertrophy with dilatation that affects the overall performance. Of the evaluation methods, the echocardiography is the most accurate one in quantifying hypertrophy, evaluation of the cardiac performance and possibility of detecting several characteristic aspects of the hypertensive cardiopathy. The transition moment from the adaptive hypertrophy to the pathological hypertrophy cannot be exactly established but it is documented that the hemodynamic and nonhemodynamic hypertrophy is a supplementary cardiovascular risk factor.